What does Odyssey Therapeutics, Inc. do?
Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company pipeline includes OD-001, an oral small molecule inhibitor of receptor-interacting protein kinase 2, which is in phase 2a trial for the treatment of ulcerative colitis;…
What is Odyssey Therapeutics, Inc.'s P/E and P/B ratio?
Odyssey Therapeutics, Inc. has a P/E ratio of -2.5 and a P/B ratio of 2.18.
What is Odyssey Therapeutics, Inc.'s debt-to-equity ratio?
Odyssey Therapeutics, Inc. has a debt-to-equity ratio of 0.06.
How much does Odyssey Therapeutics, Inc. owe compared with what it owns?
Odyssey Therapeutics, Inc. owes $0.13 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Odyssey Therapeutics, Inc.'s Positivity rank?
Odyssey Therapeutics, Inc. is ranked #4,183 of 6,774 companies globally and #2,024 of 4,000 in United States on PositoAI, with a Positivity Score of 19,814.
Does Odyssey Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Odyssey Therapeutics, Inc..
Where can I read the latest news about Odyssey Therapeutics, Inc.?
Recent headlines about Odyssey Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Odyssey Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Odyssey Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.